PharmacyCodes



Anileridina [Inn-Spanish] en es it fr

Anileridina [Inn-Spanish] Brand names, Anileridina [Inn-Spanish] Analogs

Anileridina [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Anileridina [Inn-Spanish] Chemical_Formula

C22H28N2O2

Anileridina [Inn-Spanish] RX_link

No information avaliable

Anileridina [Inn-Spanish] fda sheet

Anileridina [Inn-Spanish] msds (material safety sheet)

Anileridina [Inn-Spanish] Synthesis Reference

Weijlard et al., J. Am. Chem. Soc. 78, 2342 (1956)

Anileridina [Inn-Spanish] Molecular Weight

352.47 g/mol

Anileridina [Inn-Spanish] Melting Point

83 oC

Anileridina [Inn-Spanish] H2O Solubility

No information avaliable

Anileridina [Inn-Spanish] State

Solid

Anileridina [Inn-Spanish] LogP

4.384

Anileridina [Inn-Spanish] Dosage Forms

Liquid; Tablet

Anileridina [Inn-Spanish] Indication

For treatment and management of pain (systemic) and for use as an anesthesia adjunct.

Anileridina [Inn-Spanish] Pharmacology

Anileridine, a potent analgesic, is an analog of pethidine. Anileridine is useful for the relief of moderate to severe pain. It may also be used as an analgesic adjunct in general anesthesia in the same manner as meperidine to reduce the amount of anesthetic needed, to facilitate relaxation, and to reduce laryngospasm. In addition, anileridine exerts mild antihistaminic, spasmolytic and antitussive effects. Anileridine's main pharmacologic action is exerted on the CNS. Respiratory depression, when it occurs, is of shorter duration than that seen with morphine or meperidine when equipotent analgesic doses are used.

Anileridina [Inn-Spanish] Absorption

Anileridine is absorbed by all routes of administration.

Anileridina [Inn-Spanish] side effects and Toxicity

Symptoms of overexposure include dizziness, perspiration, a feeling of warmth, dry mouth, visual difficulty, itching, euphoria, restlessness, nervousness and excitement have been reported.

Anileridina [Inn-Spanish] Patient Information

No information avaliable

Anileridina [Inn-Spanish] Organisms Affected

Humans and other mammals